INS and type 1 diabetes mellitus: Offering insulin pumps and AID systems was first strongly recommended for T1D patients in 2022 [31], and ADA's latest 2025 Standards of Care are the first to state that AID systems should be the preferred insulin delivery method for those with T1D, with early initiation recommended [28].